Abstract
Allergic asthma is a chronic inflammatory disease primarily mediated by Th2 immune mechanisms. Exposure to antibiotics during early life is associated with an increased risk of allergic asthma, although the exact mechanism is not fully understood. In this study, mice were randomly divided into a normal saline control group (NS group), an OVA-induced asthma group (OVA group), a vancomycin treatment control group (VAN.NS group), and a vancomycin treatment the OVA-induced asthma group (VAN.OVA group). The results showed that vancomycin altered dominant species in experimental mice. The phylum level histogram showed that Bacteroides abundance was increased, and Firmicutes abundance was decreased in the OVA group. Airway inflammation and airway hyperresponsiveness (AHR) were aggravated in the vancomycin-exposed group. Enzyme-linked immunosorbent assay (ELISA) showed that the serum levels of IL-5, IL-13, and IL-33 in the OVA group were higher than those in the NS group, especially in the VAN.OVA group. The expression of GATA binding protein-3(GATA3) and retinoid acid receptor-related orphan receptor alpha (RORa) increased in the OVA group, even more so in the VAN.OVA group. Group 2 innate lymphoid cells (ILC2s) in the lung detected by flow cytometry was increased in OVA mice more than those in control mice, with a more remarkable increase in the VAN.OVA. Our results demonstrated that vancomycin used in early life could alter the intestinal microecology of mice, which, in turn, aggravates airway inflammation and upregulate type 2 innate lymphocytes.
Similar content being viewed by others
References
Papi, A., C. Brightling, S.E. Pedersen, and H.K. Reddel. 2018. Asthma. Lancet 391 (10122): 783–800.
Muehling, L.M., M.G. Lawrence, and J.A. Woodfolk. 2017. Pathogenic CD4+ T cells in patients with asthma. The Journal of Allergy and Clinical Immunology 140 (6): 1523–1540.
Kozik, A.J., and Y.J. Huang. 2019. The microbiome in asthma: Role in pathogenesis, phenotype, and response to treatment. Annals of Allergy, Asthma & Immunology 122 (3): 270–275.
Wu, P., A.S. Feldman, C. Rosas-Salazar, K. James, G. Escobar, T. Gebretsadik, S.X. Li, K.N. Carroll, E. Walsh, E. Mitchel, S. Das, R. Kumar, C. Yu, W.D. Dupont, and T.V. Hartert. 2016. Relative importance and additive effects of maternal and infant risk factors on childhood asthma. PLoS ONE 11 (3): e0151705.
Levan, S.R., K.A. Stamnes, D.L. Lin, A.R. Panzer, E. Fukui, K. McCauley, K.E. Fujimura, M. McKean, D.R. Ownby, E.M. Zoratti, H.A. Boushey, M.D. Cabana, C.C. Johnson, and S.V. Lynch. 2019. Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance. Nature Microbiology 4 (11): 1851–1861.
Brown, E.M., D.J. Kenny, and R.J. Xavier. 2019. Gut microbiota regulation of T cells during inflammation and autoimmunity. Annual Review of Immunology 37: 599–624.
Ottman, N., L. Ruokolainen, A. Suomalainen, H. Sinkko, P. Karisola, J. Lehtimäki, M. Lehto, I. Hanski, H. Alenius, and N. Fyhrquist. 2019. Soil exposure modifies the gut microbiota and supports immune tolerance in a mouse model. The Journal of Allergy and Clinical Immunology 143 (3): 1198-1206.e12.
Frati, F., C. Salvatori, C. Incorvaia, A. Bellucci, G. Di Cara, F. Marcucci, and S. Esposito. 2018. The role of the microbiome in asthma: The Gut-Lung axis. International Journal of Molecular Sciences 20 (1): 123.
Sbihi, H., R.C. Boutin, C. Cutler, M. Suen, B.B. Finlay, and S.E. Turvey. 2019. Thinking bigger: How early-life environmental exposures shape the gut microbiome and influence the development of asthma and allergic disease. Allergy 74 (11): 2103–2115.
Arrieta, M.C., L.T. Stiemsma, P.A. Dimitriu, L. Thorson, S. Russell, S. Yurist-Doutsch, B. Kuzeljevic, M.J. Gold, H.M. Britton, D.L. Lefebvre, P. Subbarao, P. Mandhane, A. Becker, K.M. McNagny, M.R. Sears, T. Kollmann, CHILD Study Investigators, W.W. Mohn, S.E. Turvey, B.B. Finlay. 2015. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Science Translational Medicine 7(307): 307ra152.
Mulder, B., K.B. Pouwels, C.C. Schuiling-Veninga, H.J. Bos, T.W. de Vries, S.S. Jick, and E. Hak. 2016. Antibiotic use during pregnancy and asthma in preschool children: The influence of confounding. Clinical and Experimental Allergy 46 (9): 1214–1226.
Torow, N., and M.W. Hornef. 2017. The neonatal window of opportunity: Setting the stage for life-long host-microbial interaction and immune homeostasis. Journal of Immunology 198 (2): 557–563.
Huang, C., F. Li, J. Wang, and Z. Tian. 2020. Innate-like lymphocytes and innate lymphoid cells in asthma. Clinical reviews in allergy & immunology 59 (3): 359–370.
Nussbaum, J.C., S.J. Van Dyken, J. von Moltke, L.E. Cheng, A. Mohapatra, A.B. Molofsky, E.E. Thornton, M.F. Krummel, A. Chawla, H.E. Liang, and R.M. Locksley. 2013. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502 (7470): 245–248.
Christianson, C.A., N.P. Goplen, I. Zafar, C. Irvin, J.T. Good Jr., D.R. Rollins, B. Gorentla, W. Liu, M.M. Gorska, H. Chu, R.J. Martin, and R. Alam. 2015. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. The Journal of Allergy and Clinical Immunology 136 (1): 59-68.e14.
Verma, M., S. Liu, L. Michalec, A. Sripada, M.M. Gorska, and R. Alam. 2018. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations. The Journal of Allergy and Clinical Immunology 142 (3): 793-803.e8.
Satoh-Takayama, N., T. Kato, Y. Motomura, T. Kageyama, N. Taguchi-Atarashi, R. Kinoshita-Daitoku, E. Kuroda, J.P. Di Santo, H. Mimuro, K. Moro, and H. Ohno. 2020. Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA. Immunity 52 (4): 635-649.e4.
Russell, S.L., M.J. Gold, L.A. Reynolds, B.P. Willing, P. Dimitriu, L. Thorson, S.A. Redpath, G. Perona-Wright, M.R. Blanchet, W.W. Mohn, B.B. Finlay, and K.M. McNagny. 2015. Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. The Journal of Allergy and Clinical Immunology 135 (1): 100–109.
Yang, X., H. Feng, X. Zhan, C. Zhang, R. Cui, L. Zhong, S. Ying, and Z. Chen. 2019. Early-life vancomycin treatment promotes airway inflammation and impairs microbiome homeostasis. Aging 11 (7): 2071–2081.
Zeng, Z., X. Lin, R. Zheng, H. Zhang, and W. Zhang. 2018. Celastrol alleviates airway hyperresponsiveness and inhibits Th17 responses in obese asthmatic mice. Frontiers in Pharmacology 9: 49.
Raftis, E.J., M.I. Delday, P. Cowie, S.M. McCluskey, M.D. Singh, A. Ettorre, and I.E. Mulder. 2018. Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration. Scientific Reports 8 (1): 12024.
Duerr, C.U., and J.H. Fritz. 2017. Isolation of group 2 innate lymphoid cells from mouse lungs. Methods in Molecular Biology 1656: 253–261.
Munyaka, P.M., E. Khafipour, and J.E. Ghia. 2014. External influence of early childhood establishment of gut microbiota and subsequent health implications. Frontiers in Pediatrics 2: 109.
Pascal, M., M. Perez-Gordo, T. Caballero, M.M. Escribese, M.N. Lopez Longo, O. Luengo, L. Manso, V. Matheu, E. Seoane, M. Zamorano, M. Labrador, and C. Mayorga. 2018. Microbiome and allergic diseases. Frontiers in Immunology 9: 1584.
Fujimura, K.E., A.R. Sitarik, S. Havstad, D.L. Lin, S. Levan, D. Fadrosh, A.R. Panzer, B. LaMere, E. Rackaityte, N.W. Lukacs, G. Wegienka, H.A. Boushey, D.R. Ownby, E.M. Zoratti, A.M. Levin, C.C. Johnson, and S.V. Lynch. 2016. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nature Medicine 22 (10): 1187–1191.
Huo, X., S. Chu, L. Hua, Y. Bao, L. Du, J. Xu, and J. Zhang. 2018. The effect of breastfeeding on the risk of asthma in high-risk children: A case-control study in Shanghai China. BMC Pregnancy and Childbirth 18 (1): 341.
Depner, M., D.H. Taft, P.V. Kirjavainen, K.M. Kalanetra, A.M. Karvonen, S. Peschel, E. Schmausser-Hechfellner, C. Roduit, R. Frei, R. Lauener, A. Divaret-Chauveau, J.C. Dalphin, J. Riedler, M. Roponen, M. Kabesch, H. Renz, J. Pekkanen, F.M. Farquharson, P. Louis, D.A. Mills, et al. 2020. Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma. Nature Medicine 26 (11): 1766–1775.
Reijnders, D., G.H. Goossens, G.D. Hermes, E.P. Neis, C.M. van der Beek, J. Most, J.J. Holst, K. Lenaerts, R.S. Kootte, M. Nieuwdorp, A.K. Groen, S.W. Olde Damink, M.V. Boekschoten, H. Smidt, E.G. Zoetendal, C.H. Dejong, and E.E. Blaak. 2016. Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: A randomized double-blind placebo-controlled trial. Cell Metabolism 24 (1): 63–74.
Vrieze, A., C. Out, S. Fuentes, L. Jonker, I. Reuling, R.S. Kootte, E. van Nood, F. Holleman, M. Knaapen, J.A. Romijn, M.R. Soeters, E.E. Blaak, G.M. Dallinga-Thie, D. Reijnders, M.T. Ackermans, M.J. Serlie, F.K. Knop, J.J. Holst, C. van der Ley, I.P. Kema, et al. 2014. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. Journal of Hepatology 60 (4): 824–831.
Isaac, S., J.U. Scher, A. Djukovic, N. Jiménez, D.R. Littman, S.B. Abramson, E.G. Pamer, and C. Ubeda. 2017. Short- and long-term effects of oral vancomycin on the human intestinal microbiota. The Journal of Antimicrobial Chemotherapy 72 (1): 128–136.
Sun, L., X. Zhang, Y. Zhang, K. Zheng, Q. Xiang, N. Chen, Z. Chen, N. Zhang, J. Zhu, and Q. He. 2019. Antibiotic-induced disruption of gut microbiota alters local metabolomes and immune responses. Frontiers in Cellular and Infection Microbiology 9: 99.
Chiu, C.Y., M.L. Cheng, M.H. Chiang, Y.L. Kuo, M.H. Tsai, C.C. Chiu, and G. Lin. 2019. Gut microbial-derived butyrate is inversely associated with IgE responses to allergens in childhood asthma. Pediatric Allergy and Immunology 30 (7): 689–697.
Chu, S., H. Yu, Y. Chen, Q. Chen, B. Wang, and J. Zhang. 2015. Periconceptional and gestational exposure to antibiotics and childhood asthma. PLoS ONE 10 (10): e0140443.
Zimmermann, P., N. Messina, W.W. Mohn, B.B. Finlay, and N. Curtis. 2019. Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: A systematic review. The Journal of allergy and Clinical Immunology 143 (2): 467–485.
Durack, J., N.E. Kimes, D.L. Lin, M. Rauch, M. McKean, K. McCauley, A.R. Panzer, J.S. Mar, M.D. Cabana, and S.V. Lynch. 2018. Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation. Nature Communications 9 (1): 707.
Kabata, H., K. Moro, S. Koyasu, and K. Asano. 2015. Group 2 innate lymphoid cells and asthma. Allergology International 64 (3): 227–234.
Vael, C., V. Nelen, S.L. Verhulst, H. Goossens, and K.N. Desager. 2008. Early intestinal Bacteroides fragilis colonisation and development of asthma. BMC Pulmonary Medicine 8: 19.
Funding
This work was supported by 1. Wenzhou Municipal Science and Technology Bureau (Y20210007). 2. Zhejiang Medical and Health Major Projects of Science and Technology (WKJ-ZJ-2133).
Author information
Authors and Affiliations
Contributions
Qiangwei Xiang wrote the paper. Wei Zhao, Weixi Zhang design and edited the paper. Methodology, Like Wang, Jinyi Wan, Hang zheng. formal analysis, Xiumei Yan, data curation, Xixi lin. All authors read, revised and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval and Consent to Participate
The study protocol was approved by Wenzhou Medical University Ethics Committee of Animal Experiments (ID Number: wydw 2020–0778).
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xiang, Q., Yan, X., Lin, X. et al. Intestinal Microflora Altered by Vancomycin Exposure in Early Life Up-regulates Type 2 Innate Lymphocyte and Aggravates Airway Inflammation in Asthmatic Mice. Inflammation 46, 509–521 (2023). https://doi.org/10.1007/s10753-022-01748-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-022-01748-4